SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-036458
Filing Date
2014-02-05
Accepted
2014-02-05 13:17:43
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d630893d10q.htm 10-Q 393783
2 EX-31.1 d630893dex311.htm EX-31.1 8560
3 EX-31.2 d630893dex312.htm EX-31.2 8768
4 EX-32.1 d630893dex321.htm EX-32.1 4613
  Complete submission text file 0001193125-14-036458.txt   3919821

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20131231.xml EX-101.INS 571666
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20131231.xsd EX-101.SCH 36924
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20131231_cal.xml EX-101.CAL 60827
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20131231_def.xml EX-101.DEF 223990
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20131231_lab.xml EX-101.LAB 304084
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20131231_pre.xml EX-101.PRE 265381
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 14575421
SIC: 2835 In Vitro & In Vivo Diagnostic Substances